Patents by Inventor Frank Robey
Frank Robey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10916859Abstract: An inflatable antenna is disclosed herein that is capable of being deployed in space and other suitable environments and configured to improve RF performance and mechanical stability. Related methods for manufacturing and deploying such inflatable antennas are also described. The inflatable antenna can be configured to form a Gregorian dual reflector confocal parabolic antenna system when inflated. Various antenna structures, mechanisms, and manufacturing and deployment techniques are also disclosed herein that improve the precision and accuracy of RF reflective surfaces of the primary and secondary reflectors, confocal alignment of the primary and secondary reflectors, mechanical stability, and/or to improve the range of RF operation. The inflatable antenna can be manufactured and deployed with less complexity and more precision than existing inflatable antennas.Type: GrantFiled: March 15, 2019Date of Patent: February 9, 2021Assignee: Massachusetts Institute of TechnologyInventors: Alan J. Fenn, Jesse Mills, Frank Robey, James W. Finnell, Jr., Bakari Hassan, Sean Crowley
-
Publication number: 20200295469Abstract: An inflatable antenna is disclosed herein that is capable of being deployed in space and other suitable environments and configured to improve RF performance and mechanical stability. Related methods for manufacturing and deploying such inflatable antennas are also described. The inflatable antenna can be configured to form a Gregorian dual reflector confocal parabolic antenna system when inflated. Various antenna structures, mechanisms, and manufacturing and deployment techniques are also disclosed herein that improve the precision and accuracy of RF reflective surfaces of the primary and secondary reflectors, confocal alignment of the primary and secondary reflectors, mechanical stability, and/or to improve the range of RF operation. The inflatable antenna can be manufactured and deployed with less complexity and more precision than existing inflatable antennas.Type: ApplicationFiled: March 15, 2019Publication date: September 17, 2020Inventors: Alan J. Fenn, Jesse Mills, Frank Robey, James W. Finnell, JR., Bakari Hassan, Sean Crowley
-
Publication number: 20140248310Abstract: Adjuvant and immunological vaccine compositions comprising modified, cationic metal oxides are disclosed, including methods of making modified, cationic metal oxides and methods of using the modified metal oxides in vaccine formulations and regimens.Type: ApplicationFiled: December 19, 2013Publication date: September 4, 2014Inventor: Frank A. Robey
-
Patent number: 6086881Abstract: The present invention is a spatially aligned conjugated composition which comprises at least one chemically modified substance which is immunologically representative of a prechosen infectious agent and provides a chemical constituent for entering into and forming a thioether bond; a plurality of chemically substituted metallic oxide particles which range from about 10-10,000 nanometers and are able to enter into a thioether bond and covalent linkage; and at least one thioether bond and linkage joining the metallic oxide particles in a controlled and spatially aligned manner to the antigen or hapten. The conjugated composition may be alternatively employed as an immunogen; as a vaccine; as a diagnostic tool and reactant; and as an analytical material suitable for testing the pharmacological activity of new compounds.Type: GrantFiled: May 15, 1998Date of Patent: July 11, 2000Assignee: Children's Medical Center Corp.Inventors: Andreas Frey, Marian R. Neutra, Frank A. Robey
-
Patent number: 5750332Abstract: The present invention relates to synthetic peptide analogues useful as therapeutic agents, immunogens or for the diagnosis of disease. In particular, it relates to peptide multimers which maintain the conformation of the native proteins from which they are derived. Peptomers constructed from peptides derived from gp120 of the human immunodeficiency virus are exemplified.Type: GrantFiled: January 19, 1995Date of Patent: May 12, 1998Assignee: The United States of America as represented by the Secretary of the Department of Health and Human ServicesInventors: Frank A. Robey, Tracy A. Harris-Kelson, Marjorie Robert-Guroff
-
Patent number: 5444150Abstract: A new amino acid derivative, N.sup..alpha. -tert-butoxycarbonyl-N.sup.e -(N-bromoacetyl-.beta.-alanyl)-L-lysine (BBAL), has been synthesized as a reagent to be used in solid-phase peptide synthesis for introducing a side-chain bromoacetyl group at any desired position in a peptide sequence. The bromoacetyl group subsequently serves as a sulfhydryl-selective cross-linking function for the preparation of cyclic peptides, peptide conjugates and polymers. BBAL residues are stable to final HF deprotection/cleavage. BBAL peptides can be directly coupled to other molecules or surfaces which possess free sulfhydryl groups by forming stable thioether linkages. Peptides containing both BBAL and cysteine residues can be self-coupled to produce either cyclic molecules or linear peptide polymers. Such peptide derivatives are useful in preparing potential peptide immunogens, vaccines and therapeutics, and for substances such as peptides linked to polymers, plastics, enamels and ceramics.Type: GrantFiled: November 19, 1993Date of Patent: August 22, 1995Assignee: The United States of America as represented by the Department of Health and Human ServicesInventors: John K. Inman, Frank A. Robey
-
Patent number: 5286846Abstract: A new amino derivative, N.sup..alpha. -tert-butoxycarbonyl-N.sup..epsilon. -(N-bromoacetyl-.beta.-alanyl)-L-lysine (BBAL), has been synthesized as a reagent to be used in solid-phase peptide synthesis for introducing a side-chain bromoacetyl group at any desired position in a peptide sequence. The bromoacetyl group subsequently serves as a sulfhydryl-selective cross-linking function for the preparation of cyclic peptides, peptide conjugates and polymers. BBAL residues are stable to final HF deprotection/cleavage. BBAL peptides can be directly coupled to other molecules or surfaces which possess free sulfhydryl groups by forming stable thioether linkages. Peptides containing both BBAL and cysteine residues can be self-coupled to produce either cyclic molecules or linear peptide polymers. Such peptide derivatives are useful in preparing potential peptide immunogens, vaccines and therapeutics, and for substances such as peptides linked to polymers, plastics, enamels and ceramics.Type: GrantFiled: June 14, 1991Date of Patent: February 15, 1994Assignee: The Government of the United States of America as represented by the Dept. of Health and Human ServicesInventors: John K. Inman, Frank A. Robey
-
Patent number: 5092885Abstract: Peptides with laminin activity are provided as follows:tyrosine-isoleucine-glycine-serine-arginine;proline-aspartine-serine-glycine-arginine; andcysteine -aspartate-proline-glycine-tyrosine-isoleucine-glycine-serine-arginine.These peptides block angiogenesis, alter the formation of capillary structures by endothelial cells, prevent the formation of excess blood vessels in tissues, and inhibit in vivo tumor cell colonization of tissues.Type: GrantFiled: November 16, 1988Date of Patent: March 3, 1992Assignee: The Government of the United States of America as Represented by the Secretary of the Department of Health and Human ServicesInventors: Yoshihiko Yamada, Jeannette O. Graf, Yukihide Iwamoto, Frank Robey, Hynda K. Kleinman, Makoto Sasaki, George R. Martin
-
Patent number: 5092876Abstract: The present invention is directed to a human serum amyloid P component peptide sequence having 12 ammo acid residues and having the sequence identified as Glu-Lys-Pro-Leu-Gln-Asn-Phe-Thr-Leu-Cys-Phe-Arg. The invention is also directed to fragments of the above peptide. Two fragments useful in the present invention have the sequence Phe-Thr-Leu-Cys-Phe-Arg and Leu-Cys-Phe-Arg. The above peptides are useful for attaching cells to substrates such as ceramics, tissue culture, dishes, polymers or enamels and thus are useful as research tools for studying particular cells. The above peptides are also useful in vivo as artificial organ replacements which attach surrounding natural cells.Type: GrantFiled: August 30, 1989Date of Patent: March 3, 1992Assignee: The United States of America as represented by the Department of Health and Human ServicesInventors: Subhash Dhawan, Frank A. Robey
-
Patent number: 5066716Abstract: A method to incorporate bromoacetyl and chloroacetyl moieties on amino groups of synthetic peptides using a standard program with an automated peptide synthesizer has been developed. The bromoacetyl and chloroacetyl-derivatized peptides react well with sulfhydryl-containing proteins and with peptides containing cysteine residues. Autopolymerization or cyclization occurs by reaction of the free sulfhydryl of cysteine in a peptide with the bromoacetyl group (or chloroacetyl group) and reactions can generally be controlled by controlling the concentrations of starting peptide in neutral pH buffers. Analytical methods for evaluating the polymers or cyclized peptides include gel filtration chromatography, reverse phase HPLC, SDS-PAGE and amino acid analysis where the degree of reaction can be evaluated by quantifying the amount of S-carboxymethylcysteine formed after HCl hydrolysis.Type: GrantFiled: December 13, 1988Date of Patent: November 19, 1991Assignee: The United States of America as represented by the Secretary of the Department of Health and Human ServicesInventors: Frank A. Robey, Raymond L. Fields, Wolfgang Lindner